Related Experiment Videos

Experience with a trigger tool for identifying adverse drug events among older adults in ambulatory primary care

R Singh1, E A McLean-Plunckett, R Kee

  • 1Primary Care Research Institute, State University of New York at Buffalo, Buffalo, New York 14215, USA. rs10@buffalo.edu

Insights

A trigger tool can help identify adverse drug events (ADEs) in older adults. Nine key triggers identified most ADEs, suggesting a shorter tool could be effective for quality improvement in primary care.

Area of Science:

  • Pharmacovigilance
  • Health Services Research
  • Geriatric Medicine

Background:

  • Adverse drug events (ADEs) are a significant concern in older adults.
  • Ambulatory primary care settings require efficient methods for ADE detection.
  • Existing trigger tools may not be optimized for primary care environments.

Purpose of the Study:

  • To assess the effectiveness of a 39-item trigger tool in identifying ADEs in older adults within primary care.
  • To determine the performance characteristics, specifically positive predictive values (PPVs), of individual triggers.
  • To identify a core set of high-yield triggers for ADE detection.

Main Methods:

  • Retrospective chart review of 1289 patients aged 65+ with cardiovascular diagnoses across six primary care practices.
  • Utilized a 39-item trigger tool to flag potential ADEs.
  • Physician and pharmacist review of flagged charts to confirm ADEs.

Main Results:

  • 50% of reviewed charts contained at least one trigger.
  • 232 ADEs were identified from 908 triggers.
  • Nine specific triggers demonstrated high PPVs and accounted for 94.4% of all detected ADEs.

Conclusions:

  • A subset of triggers can effectively identify the majority of ADEs in older adults in primary care.
  • The findings support the development of a more concise trigger tool for quality improvement.
  • Further research is needed on physician adoption of such tools in practice.
Abstract

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...